Special Issue "Proteomic Biomarkers in Human Diseases"
A special issue of Proteomes (ISSN 2227-7382).
Deadline for manuscript submissions: closed (10 March 2018)
The latest methods for protein identification and quantification offer the opportunity to systematically study disease mechanisms as well as identify biomarkers and measure markers for the diagnosis and prognosis of disease and those that might predict or monitor a patient's response to treatment. Notably, advances in mass spectrometry instrumentation and other proteomic methods are leading to advances in the field of clinical proteomics towards the multiplexed analysis of large numbers of patient samples. A key challenge in this field today is translating this wealth of knowledge into clinically useful outputs that can benefit patients and improve the efficiency of hospital laboratories.
We invite you to contribute original studies and reviews to this Special Issue that will include applications of various biomarker panels for cancer, cardiovascular, and neurological diseases, as well as the role of proteomics in other pathological processes. We are interested in receiving manuscripts describing all aspects of the current challenges in applying proteomic technologies to the development of disease biomarkers for clinical utility. These challenges include the need for analytical rigor, reproducibility between laboratories, standardization of sample collection, storage and processing, proteomics workflows, data analysis and reporting. We are particularly interested in receiving original studies covering the discovery, measurement and clinical application of protein biomarkers and their integration with other molecular and clinical data.
We look forward to receiving your manuscripts and compiling an informative collection of pertinent articles that will serve to advance the arena of disease markers.
Prof. Dr. Stephen Pennington
Prof. Dr. Jennifer Van Eyk
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Proteomes is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Clinical Proteomics
- Biomarker Discovery
- Clinical Pathology
- Technical and Analytical Control Methods
- Mass Spectrometry